Kidney Cancer Research Consortium
9 FOLLOWERS
The Kidney Cancer Research Consortium is comprised of seven partner institutions at top academic research institutions across the country. The pooled expertise of Consortium members ensures the highest quality of clinical study design, accelerated execution of clinical trials, cost-effective access to multiple research centers, and accurate interpretation and reporting of results.
Kidney Cancer Research Consortium
1y ago
The post Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma appeared first on KCRC ..read more
Kidney Cancer Research Consortium
1y ago
The post Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease appeared first on KCRC ..read more
Kidney Cancer Research Consortium
1y ago
The post Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study appeared first on KCRC ..read more
Kidney Cancer Research Consortium
1y ago
The post Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma appeared first on KCRC ..read more
Kidney Cancer Research Consortium
1y ago
The post Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma appeared first on KCRC ..read more
Kidney Cancer Research Consortium
1y ago
The post “PROBE”ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer appeared first on KCRC ..read more
Kidney Cancer Research Consortium
1y ago
The post Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma appeared first on KCRC ..read more
Kidney Cancer Research Consortium
1y ago
The post Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial appeared first on KCRC ..read more